Article
De Novo Submissions– Bethany Hills, Chair, FDA Practice (Video)
Bethany Hills, Chair of Mintz Levin's FDA Practice, discusses the difference between a de novo submissions and 510k submissions, and the benefits of utilizing the de novo pathway.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.